These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28209745)

  • 41. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
    Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
    J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Second-line therapy with paclitaxel and carboplatin for recurrent disease following first-line therapy with paclitaxel and platinum in ovarian or peritoneal carcinoma.
    Rose PG; Fusco N; Fluellen L; Rodriguez M
    J Clin Oncol; 1998 Apr; 16(4):1494-7. PubMed ID: 9552057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407).
    Nishina T; Boku N; Gotoh M; Shimada Y; Hamamoto Y; Yasui H; Yamaguchi K; Kawai H; Nakayama N; Amagai K; Mizusawa J; Nakamura K; Shirao K; Ohtsu A;
    Gastric Cancer; 2016 Jul; 19(3):902-10. PubMed ID: 26386560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is ¹⁸F-fluorodeoxyglucose positron emission tomography-based metabolic response superior to Response Evaluation Criteria In Solid Tumors-based response after two cycles of platinum-based chemotherapy in predicting clinical outcome of untreated patients with advanced non-small cell lung cancer?
    Yang JJ; Wang SX; Zhong WZ; Xu CR; Yan HH; Wu YL
    Nucl Med Commun; 2011 Dec; 32(12):1113-20. PubMed ID: 21934546
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized phase II study of ixabepilone or paclitaxel plus carboplatin in patients with non-small-cell lung cancer prospectively stratified by beta-3 tubulin status.
    Edelman MJ; Schneider CP; Tsai CM; Kim HT; Quoix E; Luft AV; Kaleta R; Mukhopadhyay P; Trifan OC; Whitaker L; Reck M
    J Clin Oncol; 2013 Jun; 31(16):1990-6. PubMed ID: 23589560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Detection of Serum Peptides in Patients with Lung Squamous Cell Carcinoma by MALDI-TOF-MS and Analysis of Their Correlation with Chemotherapy Efficacy].
    Zhao G; Xu B; Li X; Tang C; Qin H; Wang H; Yang S; Wang W; Gao H; He K; Liu X
    Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):318-325. PubMed ID: 28532539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry.
    Viúdez A; Carmona-Bayonas A; Gallego J; Lacalle A; Hernández R; Cano JM; Macías I; Custodio A; Martínez de Castro E; Sánchez A; Iglesia L; Reguera P; Visa L; Azkarate A; Sánchez-Cánovas M; Mangas M; Limón ML; Martínez-Torrón A; Asensio E; Ramchandani A; Martín-Carnicero A; Hurtado A; Cerdà P; Garrido M; Sánchez-Bayonas R; Serrano R; Jiménez-Fonseca P;
    Clin Transl Oncol; 2020 May; 22(5):734-750. PubMed ID: 31385226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparing paclitaxel-platinum with ifosfamide-platinum as the front-line chemotherapy for patients with advanced-stage uterine carcinosarcoma.
    Su MH; Wu HH; Huang HY; Lee NR; Chang WH; Lin SC; Chen YJ; Wang PH
    J Chin Med Assoc; 2022 Feb; 85(2):204-211. PubMed ID: 34698689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Third-Line Chemotherapy for Metastatic Urothelial Cancer: A Retrospective Observational Study.
    Di Lorenzo G; Buonerba C; Bellelli T; Romano C; Montanaro V; Ferro M; Benincasa A; Ribera D; Lucarelli G; De Cobelli O; Sonpavde G; De Placido S
    Medicine (Baltimore); 2015 Dec; 94(51):e2297. PubMed ID: 26705213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcomes with anti-EGFR monoclonal antibodies in metastatic and recurrent anal squamous cell carcinoma.
    Rogers JE; Jácome AAA; Ohinata A; Wolff R; Morris VK; Johnson B; Mehdizadeh A; Rothschild ND; Ahmed SU; Guerra JL; Eng C
    Expert Rev Anticancer Ther; 2020 Oct; 20(10):901-908. PubMed ID: 32799569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studies.
    Stouvenot M; Meurisse A; Saint A; Buecher B; André T; Samalin E; Jary M; El Hajbi F; Baba-Hamed N; Pernot S; Kaminsky MC; Bouché O; Desrame J; Zoubir M; Smith D; Ghiringhelli F; Parzy A; de la Fouchardiere C; Almotlak H; Vienot A; Jacquin M; Taieb J; Nguyen T; Vernerey D; Borg C; Kim S
    Eur J Cancer; 2022 Feb; 162():138-147. PubMed ID: 34995900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202).
    Rao S; Anandappa G; Capdevila J; Dahan L; Evesque L; Kim S; Saunders MP; Gilbert DC; Jensen LH; Samalin E; Spindler KL; Tamberi S; Demols A; Guren MG; Arnold D; Fakih M; Kayyal T; Cornfeld M; Tian C; Catlett M; Smith M; Spano JP
    ESMO Open; 2022 Aug; 7(4):100529. PubMed ID: 35816951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of chemotherapy regimens for first-line treatment of advanced esophageal squamous cell carcinoma in Asia: a systematic review.
    Xu J; Bai Y; Li E; Xu N; Shi D; Qian J
    Expert Rev Anticancer Ther; 2022 Sep; 22(9):981-998. PubMed ID: 35950848
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review.
    Boussios S; Seraj E; Zarkavelis G; Petrakis D; Kollas A; Kafantari A; Assi A; Tatsi K; Pavlidis N; Pentheroudakis G
    Crit Rev Oncol Hematol; 2016 Dec; 108():164-174. PubMed ID: 27931835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aurora A Functional Single Nucleotide Polymorphism (SNP) Correlates With Clinical Outcome in Patients With Advanced Solid Tumors Treated With Alisertib, an Investigational Aurora A Kinase Inhibitor.
    Niu H; Shin H; Gao F; Zhang J; Bahamon B; Danaee H; Melichar B; Schilder RJ; Coleman RL; Falchook G; Adenis A; Behbakht K; DeMichele A; Dees EC; Perez K; Matulonis U; Sawrycki P; Huebner D; Ecsedy J
    EBioMedicine; 2017 Nov; 25():50-57. PubMed ID: 29122619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The treatment landscape of advanced angiosarcoma in Asia-A multi-national collaboration from the Asian Sarcoma Consortium.
    Chen TW; Pang A; Puhaindran ME; Maw MM; Loong HH; Sriuranpong V; Chang CC; Mingmalairak S; Hirose T; Endo M; Kawai A; Farid M; Tan SH; Goh WL; Quek R; Chan JCH; Leung AKC; Ngan RKC
    Cancer Sci; 2021 Mar; 112(3):1095-1104. PubMed ID: 33393133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic and Predictive Factors in Patients with Advanced Penile Cancer Receiving Salvage (2nd or Later Line) Systemic Treatment: A Retrospective, Multi-Center Study.
    Buonerba C; Di Lorenzo G; Pond G; Cartenì G; Scagliarini S; Rozzi A; Quevedo FJ; Dorff T; Nappi L; Lanzetta G; Pagliaro L; Eigl BJ; Naik G; Ferro M; Galdiero M; De Placido S; Sonpavde G
    Front Pharmacol; 2016; 7():487. PubMed ID: 28066240
    [No Abstract]   [Full Text] [Related]  

  • 58. Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment.
    Park C; Kim M; Kwak Y; Moon KC; Kim SH; Keam B; Kim YJ; Kim TM; Kim DW
    Cancer Res Treat; 2021 Oct; 53(4):1195-1203. PubMed ID: 33540493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical Features and Prognosis of Pulmonary Lymphoepithelioma-like Carcinoma: Summary of Eighty-five Cases.
    Qin Y; Gao G; Xie X; Zhu Z; Guan W; Lin X; Xie Z; Ming O; Chen R; Zhong N; Li S; Zhou C
    Clin Lung Cancer; 2019 May; 20(3):e329-e337. PubMed ID: 30683631
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nab-paclitaxel as alternative treatment regimen in advanced cholangiocellular carcinoma.
    Unseld M; Scheithauer W; Weigl R; Kornek G; Stranzl N; Bianconi D; Brunauer G; Steger G; Zielinski CC; Prager GW
    J Gastrointest Oncol; 2016 Aug; 7(4):588-94. PubMed ID: 27563449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.